Doubling down on diabetes drugs, Eli Lilly invests $450M into Research Triangle Park facility

Doubling down on diabetes drugs, Eli Lilly invests $450M into Research Triangle Park facility

Source: 
Medical Marketing and Media
snippet: 


Eli Lilly will invest $450 million into its Research Triangle Park facility in North Carolina to boost manufacturing for its diabetes products, the company announced Tuesday.